Company Filing History:
3 out of 3,685 
3 out of 234 
1 out of 106 Years Active: 2001-2009
Title: Innovations of Shuaige Wang: A Focus on Sulfonylaminovalerolactams
Introduction
Shuaige Wang is an accomplished inventor based in West Chester, PA, with a remarkable portfolio that includes seven patents. His work primarily focuses on the development of innovative pharmaceutical compounds, particularly those that function as inhibitors for specific biological processes. Wang's contributions are notable not only for their scientific relevance but also for their implications in the medical field.
Latest Patents
Among Wang's most recent patents are the "Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors." This patent describes a series of compounds, specifically sulfonylaminovalerolactams and their derivatives, which are designed to serve as inhibitors of trypsin-like serine proteases, with a particular focus on factor Xa. These compounds are characterized by their unique chemical structure, involving Formula I, which may include pharmaceutically acceptable salt forms. The innovation is expected to have significant applications in treating conditions that require the modulation of coagulation factors.
Career Highlights
Wang has spent a substantial part of his career at renowned organizations such as Bristol-Myers Squibb Company and Bristol-Myers Squibb Pharma Company. His tenure in these companies has allowed him to contribute to groundbreaking research and development efforts that align with his patent work.
Collaborations
Throughout his career, Shuaige Wang has collaborated with esteemed colleagues, including Joanne M. Smallheer and Jennifer X. Qiao. Their joint efforts have likely enhanced the richness of his research undertakings, combining diverse expertise and perspectives in the field of pharmaceutical invention.
Conclusion
Shuaige Wang exemplifies the spirit of innovation and dedication in the realm of drug discovery and development. With his impressive array of patents, particularly focusing on valuable inhibitors like sulfonylaminovalerolactams, Wang’s contributions are poised to impact the future of pharmacology significantly. His collaborations and experiences in prominent companies highlight the importance of teamwork in advancing medical science.